MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the presence of amyloid beta (Aβ), accumulating extracellularly as amyloid plaques and phosphorylation of tau proteins, and neurofibrillary tangles (NFTs) in the brain, affecting neuronal connectivity and functioning, which results in a progressive loss of brain function (79).